Conduent Incorporated (NASDAQ: CNDT) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $9.00 price target on the stock.
LowReport
Conduent Incorporated (NASDAQ: CNDT) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $9.00 price target on the stock.
Generative AI in the Global Pharmaceutical Market 2024-2030 - Deep Learning Leads Growth, with the Drug Discovery Segment Dominating Amid Rising Demand for Large Dataset Analysis [Yahoo! Finance]
MediumReport
Generative AI in the Global Pharmaceutical Market 2024-2030 - Deep Learning Leads Growth, with the Drug Discovery Segment Dominating Amid Rising Demand for Large Dataset Analysis [Yahoo! Finance]
Cancer Registry Software Market to be propelled at a 10.4% CAGR until 2034, Reaching a Valuation of US$ 236.0 million | Future Market Insights, Inc. [Yahoo! Finance]
LowReport
Cancer Registry Software Market to be propelled at a 10.4% CAGR until 2034, Reaching a Valuation of US$ 236.0 million | Future Market Insights, Inc. [Yahoo! Finance]
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: